Policy

There is a radical and bipartisan bill making its way to Congress that could change the future of Medicare.

In certain cases, a state can recoup its medical costs by putting a claim on a deceased person's assets.

Democratic Gov. Terry McAuliffe's administration says the state would save money instead of spending it by implementing the new federal health care law.

With the average cost of an emergency room visit hovering at $1,200, funneling patients through the ER is not an effective way to manage chronic health conditions. Those who lack medical insurance aren't the only subgroup using the ER as a doctor's office.

As U.S. consumers are asked to shoulder more prescription drug costs, drugmakers say prices for brand-name medicines will keep rising, mainly because use of their products reduces other healthcare costs.

The weak correlation between Medicare and commercial insurance spending is due to negative correlations between each sector's price and the other sector's volume.

Hospitals, physicians face mounting policy and market pressure to disclose prices.

Scott Ramsey, MD, PhD, Fred Hutchinson Cancer Research Center, says that right now, only a small portion of health economics and outcomes research (HEOR) fits into the oncology model.

The promise of the Affordable Care Act is right there in its title: Affordable. Yet, anti-poverty agencies across the country fear that even with the federal financial assistance available under the law, health insurance will remain unaffordable for significant numbers of low-income Americans.

The US Chamber of Commerce says it aims to include the Affordable Care Act in its list of 2014 objectives. Nearly 2 years ago, the chamber voiced its intent to repeal the health reform bill after it was enacted in 2010.

New federal estimates show that U.S. health spending growth continued to grow at a historically low rate in 2012 even as the economy rebounded.

An annual report from the Centers for Medicare & Medicaid Services finds that health spending totaled $2.8 trillion in 2012, which accounted for 17.2% of the nation's gross domestic product (GDP) and was down slightly from the 17.3 % of GDP in 2011.

Hospitals in the U.S. have rebounded from the Great Recession and are showing stronger operating margins than in years past, even as more care shifts from inpatient to outpatient.

The panelists discuss clinicians and their perspectives on financial constraints in treatment of NSCLC.

Dr Peskin begins by stating, costs are exceedingly consequential. Cancer care and treatment is occupying, and with demographics being what they are, increasingly larger relative total cost of care across the US, including various national organizations.

Dr Peskin discusses programs such as Choosing Wisely and how providers must be mindful of high value, cost-conscious, cost-aware care.

Narrow networks are here to stay. Some of the nation's top payers and providers are leading the way.

Insurance companies aren't crazy about their share of the health law's taxes, but mostly they've complained to politicians and regulators.

Cancer drug prices have doubled in the past decade, from an average of $5,000 per month to more than $10,000.

To keep premium prices down for individuals and small businesses buying coverage through new online marketplaces, insurers have created smaller networks of hospitals. But consumers and policy experts have wondered, just how small?

Access is an important component of the Triple Aim (cost, quality, access), and it has also been stressed as a significant factor in health reform initiatives. As the influx of uninsured increasingly seeks care, and if the number of providers available to provide primary care decreases as projected, achieving access to quality and cost-effective care may become more problematic.

Enrollment in new Obamacare exchanges may be lagging, but experts said Thursday that the health law's massive expansion of Medicaid could place more than 8 million low-income people in the program before the first year is up.

There is no question that the number of accountable care organizations in Medicare and total cost of care contracts in the private sector is growing, along with the amount of care provided under these contracts.

Competition over healthcare prices and quality is coming. Transparency and the radical redesign of health insurance benefits will be its handmaiden. Companies such as General Electric are leading the way.

Reference prices, a health benefit strategy that requires patients to pay costs above a set price, may save employers and patients money, but their potential may be limited-perhaps even more so under the Patient Protection and Affordable Care Act.

The Affordable Care Act has dramatically increased the cost of buying a health insurance plan on the individual market in California, Texas, Florida, New York, Illinois, Georgia, and North Carolina, states that account for more than half of America's uninsured adults.

Reigning in costs is a key component of healthcare reform. So it is clear why it will be essential for both providers and policy makers to identify those most at risk for driving up costs.

Much of the healthcare spotlight has been squarely focused on the federal and state implementation of the Affordable Care Act (ACA). Yet, there is another fundamental shift in policy that is occurring at the private level that will change the way health insurance is offered to consumers.

Almost 80 million people with employer health plans could find their coverage canceled because they are not compliant with ObamaCare, several experts predicted.

Balancing competing goals of innovation and regulatory oversight will influence the evolution of the vendor market for certified ambulatory electronic health record products.